Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5,071,025
-
Total 13F shares
-
19,112,947
-
Share change
-
+484,939
-
Total reported value
-
$2,733,970,889
-
Put/Call ratio
-
2%
-
Price per share
-
$143.02
-
Number of holders
-
233
-
Value change
-
+$70,361,251
-
Number of buys
-
104
-
Number of sells
-
100
Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2016
As of 30 Jun 2016,
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by
233 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,112,947 shares.
The largest 10 holders included
ATLANTA CAPITAL MANAGEMENT CO L L C, VANGUARD GROUP INC, ARIEL INVESTMENTS, LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Fund Advisors, LEVIN CAPITAL STRATEGIES, L.P., BlackRock Institutional Trust Company, N.A., STATE STREET CORP, WELLS FARGO & COMPANY/MN, and NWQ INVESTMENT MANAGEMENT COMPANY, LLC.
This page lists
233
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.